Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Expression of the inhibitors of apoptosis proteins in cisplatin-resistant prostate cancer cells.

Oncology reports - 1 Oct 2005

Nomura Takeo, Yamasaki Mutsushi, Nomura Yoshio, Mimata Hiromitsu

Abstract excerpt

Acquired multi-drug resistance remains a major obstacle in the management of prostate cancer. The objective of this study was to examine whether chemoresistance could be due in part to the expression of the inhibitors of apoptosis proteins (IAPs). We established cisplatin-resistant LNCaP sublines. We examined the effects of cisplatin on cell growth and apoptosis in LNCaP cells and LNCaP sublines by...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Docetaxel
Share to Etoposide
Share to Inhibitor of Apoptosis Proteins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Paclitaxel

Share to Survivin

Share to Taxoids

Share to Tetrazolium Salts

Share to X-Linked Inhibitor of Apoptosis Protein

Source

Identifiers

PMID: 16142363

Genes

XIAP

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Expression of the inhibitors of apoptosis proteins in cisplatin-resistant prostate cancer cells.PMID 16142363Read ↗

Chemosensitivity of prostate cancer cell lines and expression of multidrug resistance-related proteinsSemantic proximity Read ↗

Cisplatin Resistance in an Ovarian Carcinoma Is Associated With a Defect in Programmed Cell Death Control Through XIAP RegulationSemantic proximity Read ↗

Cross-resistance of cisplatin selected cells to anti-microtubule agents: Role of general survival mechanismsSemantic proximity Read ↗

Protein Disulfide Isomerase 4 Drives Docetaxel Resistance in Prostate CancerSemantic proximity Read ↗

miR-130a activates apoptotic signaling through activation of caspase-8 in taxane-resistant prostate cancer cellsSemantic proximity Read ↗

Role of apoptosis and apoptosis-related proteins in the cisplatin-resistant phenotype of human tumor cell linesSemantic proximity Read ↗

Different Cytotoxic Effects of Cisplatin on Pancreatic Ductal Adenocarcinoma Cell LinesSemantic proximity Read ↗

Heterogeneous apoptotic responses of prostate cancer cell lines identify an association between sensitivity to staurosporine-induced apoptosis, expression of Bcl-2 family members, and caspase activationSemantic proximity Read ↗

RKIP Sensitizes Prostate and Breast Cancer Cells to Drug-induced ApoptosisSemantic proximity Read ↗

Generation of Cisplatin-Resistant Ovarian Cancer Cell LinesSemantic proximity Read ↗

Gene expression profiling of the androgen independent prostate cancer cells demonstrates complex mechanisms mediating resistance to docetaxelSemantic proximity Read ↗

The involvement of Bcl-2 family proteins in AKT-regulated cell survival in cisplatin resistant epithelial ovarian cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.